Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125996391	12599639	1	I	201502	20160719	20160727	20160727	EXP	GB-MHRA-EYC 00142439	PHHY2016GB099346	SANDOZ		57.00	YR		M	Y	80.73000	KG	20160727		OT	GB	GB

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125996391	12599639	1	PS	VENLAFAXINE	VENLAFAXINE HYDROCHLORIDE	1	Oral	37.5 MG, BID							77515	37.5	MG		BID

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125996391	12599639	1	Depression

Outcome of event

Event ID	CASEID	OUTC COD
125996391	12599639	OT
125996391	12599639	DS

Reactions reported

Event ID	CASEID	PT
125996391	12599639	Balance disorder
125996391	12599639	Breath sounds abnormal
125996391	12599639	Condition aggravated
125996391	12599639	Dry mouth
125996391	12599639	Dysgeusia
125996391	12599639	Headache
125996391	12599639	Loss of libido
125996391	12599639	Male orgasmic disorder
125996391	12599639	Nightmare
125996391	12599639	Orgasmic sensation decreased
125996391	12599639	Sleep apnoea syndrome
125996391	12599639	Snoring
125996391	12599639	Throat tightness
125996391	12599639	Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
125996391	12599639	1	201502		0